Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | -4.62% | +8.55% | -12.70% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 136M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -125M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 38 x |
P/E ratio 2024 * |
-0.9
x | P/E ratio 2025 * |
-0.88
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Adicet Bio, Inc.
1 day | -4.62% | ||
1 week | +8.55% | ||
Current month | +10.74% | ||
1 month | -24.31% | ||
3 months | -51.18% | ||
6 months | +24.06% | ||
Current year | -12.70% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +8.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.65 | -4.62% | 1,001,437 |
24-05-07 | 1.73 | +2.37% | 1,612,871 |
24-05-06 | 1.69 | +16.55% | 3,099,672 |
24-05-03 | 1.45 | +2.84% | 4,866,272 |
24-05-02 | 1.41 | -7.24% | 4,877,852 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.70% | 136M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- ACET Stock